Synthesis and antitumor properties of selenocoxib-1 against rat prostate adenocarcinoma cells (Q43240660)

17 November 2017

Synthesis and antitumor properties of selenocoxib-1 against rat prostate adenocarcinoma cells (English)

1 reference

17 November 2017

1 reference

prostate adenocarcinoma

1 reference

5

1 reference

17 November 2017

Dhimant Desai

1

1 reference

17 November 2017

Indu Sinha

2

1 reference

17 November 2017

Kevin Null

3

1 reference

17 November 2017

William Wolter

4

1 reference

17 November 2017

Tonya King

6

1 reference

17 November 2017

Shantu Amin

7

1 reference

17 November 2017

Raghu Sinha

8

1 reference

17 November 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

International Journal of Cancer

17 November 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

17 November 2017

127

1 reference

17 November 2017

1

1 reference

17 November 2017

230-238

1 reference

17 November 2017

Cancer statistics, 2009

1 reference

A population-based study of daily nonsteroidal anti-inflammatory drug use and prostate cancer

21 January 2018

1 reference

Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy

21 January 2018

1 reference

Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study

21 January 2018

1 reference

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

21 January 2018

1 reference

3-phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells

21 January 2018

1 reference

COX-2 inhibition: a possible role in the management of prostate cancer?

21 January 2018

1 reference

Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.

21 January 2018

1 reference

Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents

21 January 2018

1 reference

Inhibitory effects of selenium on the growth of DU-145 human prostate carcinoma cells in vitro.

21 January 2018

1 reference

Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase

21 January 2018

1 reference

Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells.

21 January 2018

1 reference

Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).

21 January 2018

1 reference

Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite.

21 January 2018

1 reference

Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer

21 January 2018

1 reference

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

21 January 2018

1 reference

Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells

21 January 2018

1 reference

Comparative excretion and tissue distribution of selenium in mice and rats following treatment with the chemopreventive agent 1,4-phenylenebis(methylene)selenocyanate

21 January 2018

1 reference

Mammary cancer prevention by regular garlic and selenium-enriched garlic

21 January 2018

1 reference

Comparison of selenium and sulfur analogs in cancer prevention

21 January 2018

1 reference

Targeting Akt3 signaling in malignant melanoma using isoselenocyanates

21 January 2018

1 reference

Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates.

21 January 2018

1 reference

Inflammatory processes of prostate tissue microenvironment drive rat prostate carcinogenesis: preventive effects of celecoxib

21 January 2018

1 reference

Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells

21 January 2018

1 reference

Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism

21 January 2018

1 reference

Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study

21 January 2018

1 reference

Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25033

1 reference

17 November 2017

1 reference